Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy

The usefulness of 2-deoxy-2-[F-18]fluoro-D-glucose (FDG)-positron emission tomography (PET) in monitoring breast cancer response to chemotherapy has previously been reported. Elevated uptake of FDG by treated tumors can persist however, particularly in the early period after treatment is initiated....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular imaging and biology 2006-01, Vol.8 (1), p.36-42
Hauptverfasser:	Pio, Betty S, Park, Cecilia K, Pietras, Richard, Hsueh, Wei-Ann, Satyamurthy, Nagichettiar, Pegram, Mark D, Czernin, Johannes, Phelps, Michael E, Silverman, Daniel H S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Agents - therapeutic use Breast cancer Breast Neoplasms - diagnostic imaging Breast Neoplasms - metabolism Breast Neoplasms - therapy Cancer therapies Dideoxynucleosides - pharmacokinetics Female Fluorine Radioisotopes - pharmacokinetics Follow-Up Studies Humans Medical treatment Middle Aged Neoplasm Metastasis - diagnostic imaging Neoplasm Metastasis - therapy Positron-Emission Tomography Predictive Value of Tests Prospective Studies Radiopharmaceuticals - pharmacokinetics Tumor Burden - drug effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!